DE3474024D1 - Contraceptive compositions based on esters of levo-norgestrel - Google Patents

Contraceptive compositions based on esters of levo-norgestrel

Info

Publication number
DE3474024D1
DE3474024D1 DE8484300611T DE3474024T DE3474024D1 DE 3474024 D1 DE3474024 D1 DE 3474024D1 DE 8484300611 T DE8484300611 T DE 8484300611T DE 3474024 T DE3474024 T DE 3474024T DE 3474024 D1 DE3474024 D1 DE 3474024D1
Authority
DE
Germany
Prior art keywords
norgestrel
levo
esters
oxime
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484300611T
Other languages
English (en)
Inventor
Sidney Department Of Ch Archer
Egon Swedish Medica Diczfalusy
Josef Department Of Chem Fried
Guiseppe Benagiano
Pierre Crabbe
Carl Djerassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
World Health Organization
Original Assignee
World Health Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Health Organization filed Critical World Health Organization
Application granted granted Critical
Publication of DE3474024D1 publication Critical patent/DE3474024D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
DE8484300611T 1983-05-19 1984-01-31 Contraceptive compositions based on esters of levo-norgestrel Expired DE3474024D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838313921A GB8313921D0 (en) 1983-05-19 1983-05-19 Contraceptive compositions

Publications (1)

Publication Number Publication Date
DE3474024D1 true DE3474024D1 (en) 1988-10-20

Family

ID=10543055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484300611T Expired DE3474024D1 (en) 1983-05-19 1984-01-31 Contraceptive compositions based on esters of levo-norgestrel

Country Status (4)

Country Link
EP (1) EP0129947B1 (de)
AT (1) ATE37185T1 (de)
DE (1) DE3474024D1 (de)
GB (1) GB8313921D0 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3511588A1 (de) * 1985-03-27 1986-10-02 Schering AG, Berlin und Bergkamen, 1000 Berlin Waessrige kristallsuspension von steroidglykoestern
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
EP1098653A2 (de) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
EP2399566A1 (de) * 2010-06-28 2011-12-28 Laboratoire HRA Pharma Verfahren zur Empfängnisverhütung einmal im Monat
AU2017223595B2 (en) * 2016-02-24 2022-11-24 Eastern Virginia Medical School An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
EP3697421B1 (de) * 2017-10-19 2024-04-17 Evestra, Inc. Länger wirkende progestin-prodrug-kontrazeptiva
US11186585B2 (en) * 2018-08-17 2021-11-30 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method

Also Published As

Publication number Publication date
EP0129947A2 (de) 1985-01-02
EP0129947A3 (en) 1985-05-22
ATE37185T1 (de) 1988-09-15
EP0129947B1 (de) 1988-09-14
GB8313921D0 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
HUT57541A (en) Fungicidal compositions comprising substituted acrylic acid esters as active ingredient and process for producing the active ingredients
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
CA2055370A1 (en) Chewing gum with prolonged flavor release incorporating unsaturated, purified monoglycerides
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
HUT40918A (en) Process for producing new galenic compositions with retard dissolution of the active agents
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
IE893161L (en) Psyllium-containing products
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
DE3474024D1 (en) Contraceptive compositions based on esters of levo-norgestrel
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
TW430561B (en) Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT63306A (en) Insecticidal compositions comprising guanide derivatives as active ingredient and process for producing the active ingredient
HUT41376A (en) Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
CA2078885A1 (en) Pharmaceutical compositions containing amethocaine
EP0351876A3 (de) Zusammensetzung zur Steigerung der Impfungswirkung
HUT57547A (en) Herbicidal compositions comprising n-phenylsulfonyl-n'-pyrimidinyl-urea derivatives as active ingredient and process for producing the active ingredient
HUT56353A (en) Herbicidal compositions comprising salicilic acid derivatives and process for producing the active ingredients
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee